These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 22456337)
21. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856 [TBL] [Abstract][Full Text] [Related]
22. The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins. Kanungo J; Zheng YL; Amin ND; Pant HC J Neurochem; 2008 Sep; 106(5):2236-48. PubMed ID: 18662245 [TBL] [Abstract][Full Text] [Related]
23. Cdk5 phosphorylates a component of the HDAC complex and regulates histone acetylation during neuronal cell death. Fu AK; Hung KW; Wong HH; Fu WY; Ip NY Neurosignals; 2013; 21(1-2):55-60. PubMed ID: 22398430 [TBL] [Abstract][Full Text] [Related]
24. Nucleocytoplasmic Cdk5 is involved in neuronal cell cycle and death in post-mitotic neurons. Zhang J; Herrup K Cell Cycle; 2011 Apr; 10(8):1208-14. PubMed ID: 21415596 [TBL] [Abstract][Full Text] [Related]
25. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases. Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857 [TBL] [Abstract][Full Text] [Related]
26. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027 [TBL] [Abstract][Full Text] [Related]
27. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses. Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169 [TBL] [Abstract][Full Text] [Related]
28. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity. Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176 [TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. Asada A; Saito T; Hisanaga S J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861 [TBL] [Abstract][Full Text] [Related]
30. Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by proteasome-mediated degradation of p35 cyclin-dependent kinase 5 activator. Endo R; Saito T; Asada A; Kawahara H; Ohshima T; Hisanaga S J Biol Chem; 2009 Sep; 284(38):26029-39. PubMed ID: 19638632 [TBL] [Abstract][Full Text] [Related]
31. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE. Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924 [TBL] [Abstract][Full Text] [Related]
33. Identification of functional domains in the neuronal Cdk5 activator protein. Poon RY; Lew J; Hunter T J Biol Chem; 1997 Feb; 272(9):5703-8. PubMed ID: 9038181 [TBL] [Abstract][Full Text] [Related]
34. Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. Zhang J; Li H; Yabut O; Fitzpatrick H; D'Arcangelo G; Herrup K J Neurosci; 2010 Apr; 30(15):5219-28. PubMed ID: 20392944 [TBL] [Abstract][Full Text] [Related]
35. Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Mitsios N; Pennucci R; Krupinski J; Sanfeliu C; Gaffney J; Kumar P; Kumar S; Juan-Babot O; Slevin M Brain Pathol; 2007 Jan; 17(1):11-23. PubMed ID: 17493033 [TBL] [Abstract][Full Text] [Related]
36. Rb and E2F-1 regulate telomerase activity in human cancer cells. Crowe DL; Nguyen DC Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653 [TBL] [Abstract][Full Text] [Related]
37. Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability. Kaminosono S; Saito T; Oyama F; Ohshima T; Asada A; Nagai Y; Nukina N; Hisanaga S J Neurosci; 2008 Aug; 28(35):8747-55. PubMed ID: 18753376 [TBL] [Abstract][Full Text] [Related]
38. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte. He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212 [TBL] [Abstract][Full Text] [Related]
39. The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity. Qu D; Li Q; Lim HY; Cheung NS; Li R; Wang JH; Qi RZ J Biol Chem; 2002 Mar; 277(9):7324-32. PubMed ID: 11741927 [TBL] [Abstract][Full Text] [Related]
40. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Maccioni RB; Otth C; Concha II; Muñoz JP Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]